Bayer plans 3 new drugs, banks on gene and cell therapy allogeneic cancer medicines

Bayer plans 3 new drugs, banks on gene and cell therapy allogeneic cancer medicines

By Anna Domanska - Jan 13, 2021

German pharma giant Bayer has plans to introduce three news drugs with annual sales potential of $1.22 billion (€1 billion) but these will not offset the fall in revenue the comp

Read More
Latest in M&A: Sanofi snaps up rival Principia Biopharma for $3.36 billion

Latest in M&A: Sanofi snaps up rival Principia Biopharma for $3.36 billion

By Christy Gren - Aug 17, 2020

French healthcare company Sanofi has agreed to acquire U.S. company Principia Biopharma Inc. for around $3.7 billion.

Read More